Status:

COMPLETED

Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients

Lead Sponsor:

Maruho North America Inc.

Conditions:

Psoriasis

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

This study is to evaluate the pharmacokinetics and safety of M518101 in male and female plaque psoriasis patients.

Eligibility Criteria

Inclusion

  • Who are able and willing to give signed informed consent
  • Who are male or females aged 18 years or older with plaque psoriasis confirmed by the Investigator.
  • Who have ≥20% of body surface area (BSA) afflicted with plaques
  • Who are neither pregnant nor breast-feeding, nor plan to become pregnant during the study.

Exclusion

  • Who have a history of allergy to vitamin D3 derivative preparations or a history of relevant drug hypersensitivity.
  • BMI \> 32.0 kg/m2
  • Who are pregnant or lactating.
  • Who have any renal or hepatic insufficiency, or clinically significant cardiac, renal or hepatic disease.
  • Who are not deemed eligible as determined by medical history, physical examination or clinical laboratory safety tests.
  • Who have clinically relevant history or presence of any disease or surgical history other than psoriasis which is likely to affect the conduct of the study.
  • Whose serum calcium levels exceed the upper limit of reference range
  • Who have used any investigational medicinal product and/or participated in any clinical study within 60 days of randomization.
  • Who have taken any durg with known effects on calcium metabolism within 30days of randomization
  • Who have been treated with any drug with a known risk of QT prolongation within 30days of randomization.

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2013

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT01844973

Start Date

April 1 2013

End Date

August 1 2013

Last Update

August 19 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Orenge County Research Center

Tustin, California, United States, 92780

Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients | DecenTrialz